• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

genetics

DNA strand genome
Pharma

2seventy brings in Genevant delivery tech for Novo Nordisk work

Bluebird bio’s oncology spinoff will use the LNP delivery technology in an in vivo gene editing collaboration with Novo Nordisk.
Nick Paul Taylor Jan 10, 2022 11:17am
A rendering of DNA breaking at the strand

Touchlight reaps $125M to expand manufacturing

Sep 16, 2021 10:20am
FDA Building

Rhythm scores first FDA nod for rare genetic-defect obesity med

Nov 30, 2020 3:37am
Sanofi and Parkinsons Foundation gene study recruitment card

Sanofi works with Parkinson's Foundation on genetic testing

Nov 18, 2020 10:47am
Test tube testing image

Biogen, PTC back BioMarin's genetic seizure testing effort

Jan 31, 2020 10:40am
FDA Building 2

AZ's struggling cancer drug nabs priority review in rare disease

Nov 14, 2019 11:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings